EBAY:NASDAQeBay Inc. Analysis
Data as of 2026-03-10 - not real-time
$92.91
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
eBay shares rallied after a robust fourth‑quarter earnings beat, lifting the price by nearly four percent. The stock is positioned just above its short‑term moving average while still under the medium‑term average, and momentum indicators such as the RSI sit in the upper half of their range, suggesting a neutral‑to‑slightly bullish outlook. The MACD histogram remains positive, reinforcing the short‑term bullish bias, though trading volume has been tapering, which tempers enthusiasm.
Fundamentally, the company delivers strong profitability with a healthy operating margin and an impressive return on equity exceeding forty percent. Valuation metrics show a moderate price‑to‑earnings multiple and a modest dividend yield supported by a low payout ratio, indicating dividend sustainability. However, a discounted cash‑flow estimate places intrinsic value well below the current market price, flagging potential overvaluation. The consumer‑cyclical sector exposure adds sensitivity to discretionary spending trends, while a low beta suggests limited market‑wide volatility exposure.
Fundamentally, the company delivers strong profitability with a healthy operating margin and an impressive return on equity exceeding forty percent. Valuation metrics show a moderate price‑to‑earnings multiple and a modest dividend yield supported by a low payout ratio, indicating dividend sustainability. However, a discounted cash‑flow estimate places intrinsic value well below the current market price, flagging potential overvaluation. The consumer‑cyclical sector exposure adds sensitivity to discretionary spending trends, while a low beta suggests limited market‑wide volatility exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Positive MACD and RSI momentum
- Decreasing volume suggests caution
- Recent earnings beat fuels short‑term optimism
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong operating cash flow and high ROE
- Modest dividend yield with low payout ratio
- Potential overvaluation relative to DCF
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable dividend and cash generation
- Resilient consumer‑spending exposure
- Valuation premium may limit upside
Key Metrics & Analysis
Financial Health
Revenue Growth15.00%
Profit Margin18.30%
P/E Ratio21.8
ROE40.85%
ROA7.80%
Debt/Equity155.62
P/B Ratio9.0
Op. Cash Flow$2.0B
Free Cash Flow$741.1M
Technical Analysis
TrendNeutral
RSI59.5
Support$78.03
Resistance$94.26
MA 20$86.81
MA 50$89.33
MA 200$86.37
MACDBullish
VolumeDecreasing
Fear & Greed Index80.13
Valuation
Fair Value$32.99
Target Price$99.13
Upside/Downside6.70%
GradeOvervalued
TypeGrowth
Dividend Yield1.33%
Risk Assessment
Beta0.58
Volatility45.16%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.